Indian equity markets demonstrated resilience on Wednesday, May 20, 2026, as both the BSE Sensex and NSE Nifty50 indexes rebounded sharply from their day's lows. The 30-share Sensex closed 127.74 points (0.17%) higher at 75,328.59, while the Nifty50 climbed 50.65 points (0.21%) to 23,668.65. This recovery saw the Sensex claw back nearly 800 points and the Nifty around 270 points from their lowest levels of the session.
Pharma Sector Leads Market Recovery
The export-focused pharmaceutical sector emerged as a significant driver of the market's rebound, with the Nifty Pharma sub-index scaling a fresh record high. This surge is attributed to investors seeking safer havens amidst broader market uncertainty and the sector benefiting from a weakening Indian rupee.
Gaurav Sharma of Globe Capital noted the consistent strong performance of the pharma sector, citing robust quarterly results and the advantageous position created by a depreciating rupee for export-oriented businesses, including IT. Kranthi Bathini, Equity Strategist at WealthMills Securities, echoed these sentiments, recommending pharma and healthcare stocks for medium- to long-term horizons, further highlighting the positive impact of the rupee's slide. Adding to the tailwinds, global demand for generic weight-loss drugs is also providing support to the sector.
Investor Caution Amid Macro Concerns
Despite the day's recovery, market strategists are advising investors to proceed with caution. Abhishek Basumallick, Co-founder and Fund Manager at Shree Rama Managers, recommended a conservative, staggered approach to investing, suggesting routes like Systematic Investment Plans (SIPs) rather than taking concentrated positions, even for long-term investors.
Kranthi Bathini also emphasized a cautious stance, suggesting a 'buy-on-dips' and 'sell-on-rallies' strategy in the current environment. VK Vijayakumar, Chief Investment Strategist at Geojit Investments, pointed to macro concerns as a market headwind for India, projecting lower GDP growth (around 6%) and higher inflation (about 5.5%) for FY27. He advised prioritizing value stocks available at fair valuations, stressing that patience is key during these testing times.
Rupee Hits New Low
Further underscoring the economic landscape, the Indian rupee slipped to a fresh record low of 96.88 against the US dollar during the trading session, impacting various sectors but providing a boost to export-driven industries like pharmaceuticals.